Evidence map›Paper›PMID 27376625›Full record

ArticleAngewandte Chemie (International ed. in English)2016

Enantioselective Allylic C-H Oxidation of Terminal Olefins to Isochromans by Palladium(II)/Chiral Sulfoxide Catalysis.

Stephen E Ammann, Wei Liu, M Christina White

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
21.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 159 citations in OpenAlex.

  1. Catalytic Enantioselective Synthesis of 1,1-Disubstituted Isochromans.Journal of the American Chemical Society · 2026
    Article
  2. Article
  3. C(spJournal of the American Chemical Society · 2025
    Article
  4. Photoinduced Copper-Catalyzed Enantioselective Allylic C(Journal of the American Chemical Society · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stephen E AmmannRoger Adams Laboratory, Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
Wei LiuRoger Adams Laboratory, Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
M Christina WhiteRoger Adams Laboratory, Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. mcwhite7@illinois.edu.
University of Illinois Urbana-Champaign · US

Funding

Hydrocarbon Oxidation Methods for SynthesisR01GM076153 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI WHITE, MARIA · 2006 to 2015
$2.8M
NIGMS NIH HHS R01 GM076153
6 · The paper itself

Abstract

The enantioselective synthesis of isochroman motifs has been accomplished by palladium(II)-catalyzed allylic C-H oxidation from terminal olefin precursors. Critical to the success of this goal was the development and utilization of a novel chiral aryl sulfoxide-oxazoline (ArSOX) ligand. The allylic C-H oxidation reaction proceeds with the broadest scope and highest levels of asymmetric induction reported to date (avg. 92 % ee, 13 examples with greater than 90 % ee).

Indexed as

AlkenesAllyl CompoundsCatalysisChromansMolecular StructureOxidation-ReductionPalladiumStereoisomerismSulfoxidesAlkenesAllyl CompoundsChromansPalladiumSulfoxidesasymmetric catalysisC−H activationoxidationpalladiumS ligands

Identifiers

PMID27376625
PMCPMC5729747
OpenAlexW2464893849

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.